Unusual 11 Mid-Day Movers 06/29: (AMPE) (STZ) (AZZ) Higher; (RIMM) (UNIS) (CAMP) Lower
Tweet Send to a Friend
Up)
Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE) 30.0% HIGHER; moving higher on bullish SA post, mostly highlighting a June 21st press release. Volume is very heavy today.
Constellation Brands (NYSE: STZ) 23.1% HIGHER; reported Q1 EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $635 million versus the consensus estimate of $645.5 million. Constellation also signed a definitive agreement with Anheuser-Busch InBev SA/NV (NYSE: BUD) to purchase the remaining 50 percent interest in Crown Imports LLC as AB InBev completes its proposed acquisition of Modelo. The purchase price is $1.85 billion and represents 50 percent of a multiple of approximately 8.5 times Crown's EBIT. The transaction, which is subject to regulatory approval, is expected to close during the first quarter of calendar 2013.
AZZ, Inc. (NYSE: AZZ) 18.4% HIGHER; reported Q2 EPS of $1.26, $0.45 better than the analyst estimate of $0.81. Revenue for the quarter came in at $127.1 million versus the consensus estimate of $124.36 million. Additionally, the Company announced that the Board of Directors, at its regularly scheduled quarterly meeting, declared a 2 for 1 stock split of the Company's Common Stock in the form of a 100% stock dividend, payable on July 30, 2012 to shareholders of record as of July 16, 2012, with a broker's cut-off date of July 23, 2012. The stock dividend entitles each shareholder of record as of July 16, 2012 to receive one additional share of common stock for each share then owned. Prior to the most recent quarterly filing of May 31, 2012, the company had outstanding approximately 12.6 million shares. Upon completion of the stock dividend, the outstanding shares will be approximately 25.3 million shares. The share and per share information in this release has not been adjusted to reflect the stock split.
Research In Motion (Nasdaq: RIMM) 18.7% LOWER; reported revs of $2.81 billion and an adjusted loss of 37 cents per share. The Street was looking for revs of $3.13 billion and a loss of 1 cent per share. Will delay BB10 launch until Q113 and plans to cut 5,000 jobs. For more, click here.
Smith & Wesson Holding Corp. (Nasdaq: SWHC) 17.9% HIGHER; reported Q4 EPS of $0.27, $0.10 better than the analyst estimate of $0.17. Revenue for the quarter came in at $129.8 million versus the consensus estimate of $126.53 million. Sees Q1 2013 EPS of $0.16-$0.19, versus the consensus of $0.12. Smith & Wesson Holding Corp. sees Q1 2013 revenue of $125-$130 million, versus the consensus of $112.55 million. Also sees FY2013 EPS of $0.60-$0.65, versus the consensus of $0.50. Smith & Wesson Holding Corp. sees FY2013 revenue of $485-$505 million, versus the consensus of $466.0 million.
ValueClick, Inc. (Nasdaq: VCLK) 15.4% HIGHER; announced updated expectations for financial results for the second quarter ended June 30, 2012, an update on its stock repurchase program, and a $50 million increase to its credit facility. For Q212, sees revs at high-end of $155 million to $160 million range and adjusted-EBITDA at high-end of $46 million to $48 million range. The Street is looking for revs of $157.3 million. The Company also announced a new $100 millon increase to its common stock buyback program and $50 million increase on its revolving facility.
Synta Pharma. (Nasdaq: SNTA) 13.5% HIGHER; Jefferies issued some positive comments on the pharma today, saying the recent selloff was "excessive."
Unilife Corporation (Nasdaq: UNIS) 13.0% LOWER; priced its underwritten offering of 6,154,000 shares of common stock at a price of $3.25 per share.
Calamp Corp. (Nasdaq: CAMP) 10.6% LOWER; reported Q1 EPS of $0.18, $0.05 better than the analyst estimate of $0.13. Revenue for the quarter came in at $43.9 million versus the consensus estimate of $43.5 million. Calamp sees Q213 revenue of $41 - $45 million, versus the consensus of $41.4 million.
Impax Laboratories, Inc. (Nasdaq: IPXL) 8.0% LOWER; announced that Arthur A. Koch, the Company’s Executive Vice President, Finance, and Chief Financial Officer, has informed the Company of his decision to resign from his position with the Company to pursue other opportunities. Mr. Koch will assist the Company to help ensure a smooth transition.
Nike Inc. (NYSE: NKE) 8.0% LOWER; reported Q4 EPS of $1.17, $0.21 worse than the analyst estimate of $1.38. Revenue for the quarter came in at $6.47 billion versus the consensus estimate of $6.53 billion. Future orders up 12 percent.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Constellation Brands (NYSE: STZ) 23.1% HIGHER; reported Q1 EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $635 million versus the consensus estimate of $645.5 million. Constellation also signed a definitive agreement with Anheuser-Busch InBev SA/NV (NYSE: BUD) to purchase the remaining 50 percent interest in Crown Imports LLC as AB InBev completes its proposed acquisition of Modelo. The purchase price is $1.85 billion and represents 50 percent of a multiple of approximately 8.5 times Crown's EBIT. The transaction, which is subject to regulatory approval, is expected to close during the first quarter of calendar 2013.
AZZ, Inc. (NYSE: AZZ) 18.4% HIGHER; reported Q2 EPS of $1.26, $0.45 better than the analyst estimate of $0.81. Revenue for the quarter came in at $127.1 million versus the consensus estimate of $124.36 million. Additionally, the Company announced that the Board of Directors, at its regularly scheduled quarterly meeting, declared a 2 for 1 stock split of the Company's Common Stock in the form of a 100% stock dividend, payable on July 30, 2012 to shareholders of record as of July 16, 2012, with a broker's cut-off date of July 23, 2012. The stock dividend entitles each shareholder of record as of July 16, 2012 to receive one additional share of common stock for each share then owned. Prior to the most recent quarterly filing of May 31, 2012, the company had outstanding approximately 12.6 million shares. Upon completion of the stock dividend, the outstanding shares will be approximately 25.3 million shares. The share and per share information in this release has not been adjusted to reflect the stock split.
Research In Motion (Nasdaq: RIMM) 18.7% LOWER; reported revs of $2.81 billion and an adjusted loss of 37 cents per share. The Street was looking for revs of $3.13 billion and a loss of 1 cent per share. Will delay BB10 launch until Q113 and plans to cut 5,000 jobs. For more, click here.
Smith & Wesson Holding Corp. (Nasdaq: SWHC) 17.9% HIGHER; reported Q4 EPS of $0.27, $0.10 better than the analyst estimate of $0.17. Revenue for the quarter came in at $129.8 million versus the consensus estimate of $126.53 million. Sees Q1 2013 EPS of $0.16-$0.19, versus the consensus of $0.12. Smith & Wesson Holding Corp. sees Q1 2013 revenue of $125-$130 million, versus the consensus of $112.55 million. Also sees FY2013 EPS of $0.60-$0.65, versus the consensus of $0.50. Smith & Wesson Holding Corp. sees FY2013 revenue of $485-$505 million, versus the consensus of $466.0 million.
ValueClick, Inc. (Nasdaq: VCLK) 15.4% HIGHER; announced updated expectations for financial results for the second quarter ended June 30, 2012, an update on its stock repurchase program, and a $50 million increase to its credit facility. For Q212, sees revs at high-end of $155 million to $160 million range and adjusted-EBITDA at high-end of $46 million to $48 million range. The Street is looking for revs of $157.3 million. The Company also announced a new $100 millon increase to its common stock buyback program and $50 million increase on its revolving facility.
Synta Pharma. (Nasdaq: SNTA) 13.5% HIGHER; Jefferies issued some positive comments on the pharma today, saying the recent selloff was "excessive."
Unilife Corporation (Nasdaq: UNIS) 13.0% LOWER; priced its underwritten offering of 6,154,000 shares of common stock at a price of $3.25 per share.
Calamp Corp. (Nasdaq: CAMP) 10.6% LOWER; reported Q1 EPS of $0.18, $0.05 better than the analyst estimate of $0.13. Revenue for the quarter came in at $43.9 million versus the consensus estimate of $43.5 million. Calamp sees Q213 revenue of $41 - $45 million, versus the consensus of $41.4 million.
Impax Laboratories, Inc. (Nasdaq: IPXL) 8.0% LOWER; announced that Arthur A. Koch, the Company’s Executive Vice President, Finance, and Chief Financial Officer, has informed the Company of his decision to resign from his position with the Company to pursue other opportunities. Mr. Koch will assist the Company to help ensure a smooth transition.
Nike Inc. (NYSE: NKE) 8.0% LOWER; reported Q4 EPS of $1.17, $0.21 worse than the analyst estimate of $1.38. Revenue for the quarter came in at $6.47 billion versus the consensus estimate of $6.53 billion. Future orders up 12 percent.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Tesla (TSLA) Ramps Higher (GM)
- Trading Radar for 06/19: FedEx (FDX), Micron (MU), Jabil Circuit (JBL), Red Hat (RHT) Report
- Notable 52-Week Highs and Lows of the Day 06/19: (ALU) (CYTK) (NVDA) High; (TTEK) (PANW) Low
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Jefferies & Co, Dividend, Unusual 11 Mid-Day Movers, Stock Buyback, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
